Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.

about

Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.

Item

http://www.wikidata.org/entity/Q49199328

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Detailed analysis of retinal m ...... ab or triamcinolone treatment.

@en

type

Item

label

Detailed analysis of retinal m ...... ab or triamcinolone treatment.

@en

prefLabel

Detailed analysis of retinal m ...... ab or triamcinolone treatment.

@en

P1476

Detailed analysis of retinal m ...... ab or triamcinolone treatment.

@en

P2093

Christoph Mitsch

http://www.w3.org/2001/XMLSchema#string

Christoph Scholda

http://www.w3.org/2001/XMLSchema#string

Jan Lammer

http://www.w3.org/2001/XMLSchema#string

Janhvi Mehta

http://www.w3.org/2001/XMLSchema#string

Katharina Kriechbaum

http://www.w3.org/2001/XMLSchema#string

Manuela Schober

http://www.w3.org/2001/XMLSchema#string

Sonja G Karst

http://www.w3.org/2001/XMLSchema#string

P2860

Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema.

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

A systematic correlation between morphology and functional alterations in diabetic macular edema.

Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial.

SAVE: a grading protocol for clinically significant diabetic macular oedema based on optical coherence tomography and fluorescein angiography.

Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema

Interobserver agreement in detecting spectral-domain optical coherence tomography features of diabetic macular edema.

Global prevalence and major risk factors of diabetic retinopathy.

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.

P2888

s00417-017-3828-1

P304

49-58

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00417-017-3828-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

256

http://www.w3.org/2001/XMLSchema#string

P50

Michael Kundi

Ursula Schmidt-Erfurth

P577

2017-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092417150

http://www.w3.org/2001/XMLSchema#string

P698

29080915

http://www.w3.org/2001/XMLSchema#string

P932

5748439

http://www.w3.org/2001/XMLSchema#string